ArticleLancet regional health. Americas2023
The high price that Colombia has paid for its lack of biotechnological sovereignty.
Camilo Guzman T et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it